News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,895 Results
Type
Article (39143)
Company Profile (283)
Press Release (648469)
Section
Business (203900)
Career Advice (1996)
Deals (35371)
Drug Delivery (89)
Drug Development (80846)
Employer Resources (168)
FDA (16098)
Job Trends (14808)
News (344638)
Policy (32450)
Tag
Academia (2530)
Alliances (49183)
Alzheimer's disease (1257)
Approvals (16049)
Artificial intelligence (144)
Bankruptcy (352)
Best Places to Work (11581)
Biotechnology (200)
Breast cancer (188)
Cancer (1365)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (281)
Clinical research (64692)
Collaboration (482)
Compensation (260)
COVID-19 (2541)
C-suite (108)
Data (1389)
Diabetes (172)
Diagnostics (6170)
Earnings (84892)
Employer resources (146)
Events (110005)
Executive appointments (394)
FDA (16767)
Funding (426)
Gene therapy (195)
GLP-1 (597)
Government (4333)
Healthcare (18693)
Infectious disease (2633)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16339)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7861)
Lung cancer (197)
Lymphoma (98)
Manufacturing (206)
Medical device (13211)
Medtech (13216)
Mergers & acquisitions (19192)
Metabolic disorders (452)
Neuroscience (1577)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1693)
Obesity (258)
Opinion (183)
Patents (117)
People (56455)
Phase I (20119)
Phase II (28493)
Phase III (21237)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (259)
Real estate (5890)
Regulatory (21664)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1460)
Startups (3562)
United States (15141)
Vaccines (563)
Weight loss (181)
Date
Last 7 days (579)
Last 30 days (2250)
Last 365 days (35160)
2024 (35002)
2023 (40077)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (195)
Asia (37266)
Australia (6087)
California (3809)
Canada (1449)
China (304)
Colorado (171)
Connecticut (176)
Europe (79824)
Florida (533)
Georgia (135)
Illinois (384)
Indiana (224)
Maryland (626)
Massachusetts (2959)
Michigan (172)
Minnesota (290)
New Jersey (1100)
New York (1080)
North Carolina (742)
Northern California (1693)
Ohio (146)
Pennsylvania (923)
South America (1091)
Southern California (1460)
Texas (547)
Utah (108)
Washington State (399)
687,895 Results for "pharmascience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Pharmascience Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Montreal, Quebec--(Newsfile Corp. - April 3, 2024) - Pharmascience Inc., the largest Canadian-owned pharmaceutical company and a leader in the Canadian generic market, will be participating in the 2024 Bloom Burton & Co
April 3, 2024
·
2 min read
Press Releases
Pharmascience Canada launches Pr pms-PALBOCICLIB, a treatment for breast cancer
November 27, 2024
·
2 min read
Pharmascience Expands its Contract Development and Manufacturing Organization (CDMO) Services With a New Commercial Business Unit
Last Fall, Pharmascience, the largest Canadian-owned pharmaceutical company, announced a major $120 million sterile injectable manufacturing facility expansion at its Candiac site.
February 26, 2024
·
3 min read
Pharmascience Canada Launches an Extension to its New Methotrexate Product Line: pms-METHOTREXATE INJECTION 50mg/ml
Pharmascience Canada is proud to announce the launch of pms- METHOTREXATE INJECTION (methotrexate injection) 50 mg/ml, a drug indicated for the treatment of psoriasis, psoriatic arthritis and rheumatoid arthritis in adults aged 18 to 65 with severe disabling conditions, when other treatments do not work.
March 15, 2024
·
2 min read
BioMidwest
Infinity Laboratories Unveils New Brand at AAPS 2023 PharmaSci 360 in Orlando, FL
Infinity Laboratories is thrilled to officially unveil its new brand identity at the AAPS 2023 PharmaSci 360 Annual Meeting from October 22nd to the 25th in Orlando, Florida.
October 23, 2023
·
2 min read
Business
PHARMASCIENCE INC. ANNOUNCES APPOINTMENT OF MARTIN ARES AS NEW CHIEF EXECUTIVE OFFICER
Pharmascience Inc. is pleased to announce today the appointment of Martin Arès as Chief Executive Officer, effective January 3, 2023.
November 16, 2022
·
2 min read
Pharmascience Canada launches another generic drug with multiple indications
Pharmascience Canada launches the generic Prpms-TOFACITINIB in the Canadian market, last November 2022.
January 16, 2023
·
2 min read
Pharmascience Canada launches pms-APREMILAST, a generic drug with multiple indications
Pharmascience Canada is pleased to launch pms-APREMILAST, only in 30 mg tablets in Canada.
January 17, 2023
·
2 min read
Pharmascience Canada is thrilled to launch (PR)pms-TERIFLUNOMIDE
Pharmascience Canada, a division of Pharmascience Inc. is proud to launch PRpms-TERIFLUNOMIDE, a generic drug with demonstrated bioequivalence to the brand name AUBAGIO®.
May 27, 2022
·
1 min read
Business
Pendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal, Monovisc, and Orthovisc
Pendopharm is pleased to announce the renewal of its exclusive distribution agreement with Anika Therapeutics Inc (NASDAQ: ANIK) (Anika) for Cingal ® , Monovisc ® and Orthovisc ® through the end of 2030.
May 16, 2024
·
2 min read
1 of 68,790
Next
